• Subject: Re: Have you read this?
  • From: DAsmussen@xxxxxxx
  • Date: Mon, 17 Jan 2000 18:37:52 EST


In a message dated 1/14/00 8:41:40 AM Eastern Standard Time, boldt@ca.ibm.com 

> >Your idea is good, but the premise simply will not work for RPG.  We've 
>  >several "code posting" areas here in the past, but they've failed because:
>  >...
>  Hi Dean!  I think previous efforts all missed the point somehow.  Look
>  at Leslie's web site at <http://www.springfieldtn.net/users/leslier/>.
>  I think he understands the concept and is taking the right approach.
>  Since there seems to be some interest, I think it's worth supporting.
>  Rather than finding reasons why it won't work, why not help to make it
>  work!

Well, Monsiour Russell has done well.  The proof will be in whether or not he 
receives any content -- _THAT_ was the cause of failure for the other sites, 
many of which I am sure still operate as they were offered by prominent (and 
current) members of this list.  I'm not _TRYING_ to find reasons why it won't 
work, just _STATING_ reasons that it hasn't worked in the past.  I would 
absolutely _LOVE_ to see Leslie's forum take off!  So would "News/400", eh :)?

Dean Asmussen
Enterprise Systems Consulting, Inc.
Fuquay-Varina, NC  USA
E-mail:  DAsmussen@aol.com

"Experience is a wonderful thing.  It enables you to recognize a mistake when 
you make it again." -- Anonymous
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com

This thread ...

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].